CORRESP Filing
Emergent BioSolutions Inc.
Date: Aug. 13, 2025 · CIK: 0001367644 · Accession: 0001193125-25-179811
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289359
Letter
Re: Emergent BioSolutions Inc. Registration Statement on Form S-3 File No. 333-289359 Filed August 7, 2025 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Emergent BioSolutions Inc. hereby respectfully requests that the effective date for the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on August 15, 2025, or as soon as practicable thereafter. Should you have any questions or comments regarding the foregoing, please contact Matthew C. Franker or Julie M. Plyler of Covington & Burling LLP at (202) 662-5895 or (212) 841-1090, respectively.
August 13, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Respectfully,
Emergent BioSolutions Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP August 13, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Emergent BioSolutions Inc. Registration Statement on Form S-3 File No. 333-289359 Filed August 7, 2025 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Emergent BioSolutions Inc. hereby respectfully requests that the effective date for the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on August 15, 2025, or as soon as practicable thereafter. Should you have any questions or comments regarding the foregoing, please contact Matthew C. Franker or Julie M. Plyler of Covington & Burling LLP at (202) 662-5895 or (212) 841-1090, respectively. Respectfully, Emergent BioSolutions Inc. By: /s/ Jessica Perl Name: Jessica Perl Title: Senior Vice President, General Counsel and Corporate Secretary cc: Doris Stacey Gama Matthew C. Franker Julie M. Plyler